Constitutive activity and inverse agonism at the α(₁a) and α(₁b) adrenergic receptor subtypes.
The α(1b)-adrenergic receptor (AR) was, after rhodopsin, the first G protein-coupled receptor (GPCR) in which point mutations were shown to trigger constitutive (agonist-independent) activity. Constitutively activating mutations have been found in other AR subtypes as well as in several GPCRs. This chapter briefly summarizes the main findings on constitutively active mutants of the α(1a)- and α(1b)-AR subtypes and the methods used to predict activating mutations, to measure constitutive activity of Gq-coupled receptors and to investigate inverse agonism. In addition, it highlights the implications of studies on constitutively active AR mutants on elucidating the molecular mechanisms of receptor activation and drug action.
Department of General and Environmental Physiology, University of Bari, Italy.
Susanna
S
Cotecchia
D000818:Animals; D054314:Drug Inverse Agonism; D006801:Humans; D016297:Mutagenesis, Site-Directed / Q000379:methods; D009154:Mutation; D017434:Protein Structure, Tertiary; D018340:Receptors, Adrenergic, alpha-1 / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*
D018340:Receptors, Adrenergic, alpha-1